Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interleukin 4 receptor alpha chain is a type I transmembrane receptor subunit encoded by the IL4R gene (CD124). It binds interleukin-4 and interleukin-13, forming receptor complexes crucial for immune regulation. The alpha chain is essential for high-affinity ligand recognition and signal transduction via the JAK/STAT pathway, particularly through STAT6. IL4Rα functions in Th2 cell differentiation, alternative macrophage activation, and regulation of IgE synthesis, with roles in inflammation and allergic responses. Variants and expression levels are associated with atopic diseases, infection susceptibility, and certain cancers. Therapeutically, IL4Rα is targeted by agents like dupilumab for allergy and investigational fusion toxins for oncology.
Blockade of IL-4 and IL-13 signaling by antagonism or neutralization of IL4Rα. Inhibition of JAK/STAT-mediated immune responses. Induction of cell death via delivery of cytotoxic agents to IL4Rα-expressing tumor cells.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin 4 receptor alpha chain (IL4Rα).